Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 29.5 | 58 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 120.0 | 55 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 91.0 | 47 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 27.0 | 42 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 25.0 | 44 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 37.5 | 46 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 48.0 | 42 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 194.5 | 42 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 194.0 | 45 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 41.0 | 38 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | b-NGF | 40.5 | 40 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 27.0 | 59 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | b-NGF | 20.5 | 56 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 127.0 | 54 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | b-NGF | 120.0 | 55 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | b-NGF | 25.0 | 53 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | b-NGF | 18.0 | 51 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 25.0 | 44 | ||||
RA2159 | 2 | b-NGF | 22.0 | 37 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 174.0 | 31 | ||||
N2645 | 2 | b-NGF | 162.0 | 38 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | b-NGF | 24.0 | 39 | ||||
RA2708 | 2 | b-NGF | 14.0 | 41 | |||||||
0 | b-NGF | 12.0 | 31 | ||||||||
0 | b-NGF | 13.0 | 47 |